Market Closed -
Xetra
16:36:06 26/04/2024 BST
|
5-day change
|
1st Jan Change
|
12.9
EUR
|
+0.78%
|
|
+18.35%
|
+29.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,477
|
1,170
|
1,104
|
962.6
|
1,024
|
669.4
|
Enterprise Value (EV)
1 |
1,320
|
1,107
|
1,008
|
830.2
|
886
|
476.4
|
P/E ratio
|
30.2
x
|
27
x
|
825
x
|
34.2
x
|
40.7
x
|
17.3
x
|
Yield
|
1.31%
|
-
|
-
|
-
|
0.98%
|
-
|
Capitalization / Revenue
|
1.05
x
|
0.79
x
|
0.71
x
|
0.6
x
|
0.62
x
|
0.39
x
|
EV / Revenue
|
0.94
x
|
0.75
x
|
0.65
x
|
0.52
x
|
0.54
x
|
0.27
x
|
EV / EBITDA
|
10.9
x
|
13.3
x
|
11.9
x
|
8.76
x
|
9.08
x
|
4.69
x
|
EV / FCF
|
-14.1
x
|
-8.49
x
|
37.3
x
|
-420
x
|
-26.4
x
|
21.3
x
|
FCF Yield
|
-7.1%
|
-11.8%
|
2.68%
|
-0.24%
|
-3.79%
|
4.69%
|
Price to Book
|
1.3
x
|
1.01
x
|
0.95
x
|
0.8
x
|
0.84
x
|
0.53
x
|
Nbr of stocks (in thousands)
|
66,938
|
66,938
|
66,938
|
66,938
|
66,938
|
66,938
|
Reference price
2 |
22.06
|
17.48
|
16.50
|
14.38
|
15.30
|
10.00
|
Announcement Date
|
29/03/19
|
24/03/20
|
25/03/21
|
24/03/22
|
30/03/23
|
28/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,411
|
1,485
|
1,557
|
1,591
|
1,654
|
1,735
|
EBITDA
1 |
121.4
|
82.96
|
84.45
|
94.82
|
97.61
|
101.5
|
EBIT
1 |
60.82
|
17.66
|
18.05
|
27.72
|
31.31
|
39
|
Operating Margin
|
4.31%
|
1.19%
|
1.16%
|
1.74%
|
1.89%
|
2.25%
|
Earnings before Tax (EBT)
1 |
63.18
|
54.24
|
3.932
|
27.36
|
33.63
|
47.73
|
Net income
1 |
48.99
|
43.28
|
1.451
|
28.3
|
25.14
|
38.71
|
Net margin
|
3.47%
|
2.91%
|
0.09%
|
1.78%
|
1.52%
|
2.23%
|
EPS
2 |
0.7300
|
0.6465
|
0.0200
|
0.4200
|
0.3756
|
0.5783
|
Free Cash Flow
1 |
-93.66
|
-130.3
|
27
|
-1.976
|
-33.6
|
22.36
|
FCF margin
|
-6.64%
|
-8.77%
|
1.73%
|
-0.12%
|
-2.03%
|
1.29%
|
FCF Conversion (EBITDA)
|
-
|
-
|
31.98%
|
-
|
-
|
22.03%
|
FCF Conversion (Net income)
|
-
|
-
|
1,860.98%
|
-
|
-
|
57.76%
|
Dividend per Share
2 |
0.2900
|
-
|
-
|
-
|
0.1500
|
-
|
Announcement Date
|
29/03/19
|
24/03/20
|
25/03/21
|
24/03/22
|
30/03/23
|
28/03/24
|
Fiscal Period: December |
2022 Q2
|
2022 Q3
|
---|
Net sales
1 |
-
|
356.1
|
EBITDA
|
-
|
-
|
EBIT
1 |
-
|
6.145
|
Operating Margin
|
-
|
1.73%
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
10.52
|
-
|
Net margin
|
-
|
-
|
EPS
|
0.1600
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
04/08/22
|
10/11/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
157
|
63.5
|
96.8
|
132
|
138
|
193
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-93.7
|
-130
|
27
|
-1.98
|
-33.6
|
22.4
|
ROE (net income / shareholders' equity)
|
4.48%
|
3.79%
|
0.21%
|
2.5%
|
2.18%
|
3.17%
|
ROA (Net income/ Total Assets)
|
2.48%
|
0.69%
|
0.69%
|
1.05%
|
1.16%
|
1.4%
|
Assets
1 |
1,972
|
6,317
|
209.8
|
2,691
|
2,165
|
2,760
|
Book Value Per Share
2 |
17.00
|
17.40
|
17.40
|
17.90
|
18.30
|
18.70
|
Cash Flow per Share
2 |
1.980
|
1.910
|
1.360
|
1.890
|
1.160
|
3.080
|
Capex
1 |
163
|
115
|
97
|
77.8
|
58.2
|
62.8
|
Capex / Sales
|
11.58%
|
7.71%
|
6.23%
|
4.89%
|
3.52%
|
3.62%
|
Announcement Date
|
29/03/19
|
24/03/20
|
25/03/21
|
24/03/22
|
30/03/23
|
28/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +29.00% | 922M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|